2022
DOI: 10.1111/clr.13935
|View full text |Cite
|
Sign up to set email alerts
|

Long‐term clinical outcomes of short implant (6mm) in relation to Implant Disease Risk Assessment (IDRA)

Abstract: Aim:To evaluate the long-term survival of short implants and to investigate the association of the Implant Disease Risk Assessment (IDRA) with the occurrence of biological complications. Material and Methods:This study was designed as a cohort study with a median follow-up of 10.0 years. Patients who had received 6-mm implants were reviewed and assigned into low-, moderate-, and high-risk groups (Group L, M, and H) based on the IDRA tool. The implant survival, biological complications, soft tissue condition, h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…Even more, before assessing prognosis, several clinical factors should be considered such as, for instance, the individual susceptibility underlying the host response to the biofilm, the higher prevalence of biological complications, splinted or non-splinted implants, and data concerning oral hygiene. All these features are gathered in the Implant Disease Risk Assessment (IDRA) [52], where are referred the Fig. 4 Funnel plot graph illustrating the publication bias and the systematic heterogeneity of the included studies.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Even more, before assessing prognosis, several clinical factors should be considered such as, for instance, the individual susceptibility underlying the host response to the biofilm, the higher prevalence of biological complications, splinted or non-splinted implants, and data concerning oral hygiene. All these features are gathered in the Implant Disease Risk Assessment (IDRA) [52], where are referred the Fig. 4 Funnel plot graph illustrating the publication bias and the systematic heterogeneity of the included studies.…”
Section: Discussionmentioning
confidence: 99%
“…Even more, before assessing prognosis, several clinical factors should be considered such as, for instance, the individual susceptibility underlying the host response to the biofilm, the higher prevalence of biological complications, splinted or non-splinted implants, and data concerning oral hygiene. All these features are gathered in the Implant Disease Risk Assessment (IDRA) [ 52 ], where are referred the history of periodontitis, the percentage of tooth and implant sites with BOP, the number of tooth and implant sites with PD ≥ 5 mm, factors of radiographic bone loss in relation to age, the periodontitis susceptibility, the compliance of patients with supportive periodontal therapy, distance from the restorative margin to the bone crest, and factors related to the implant-supported prosthesis. Additionally, the shortcoming of determining the overall patient’s risk, not only the 2 mm bone loss, based only on the targeted 6-mm implant should be realized.…”
Section: Discussionmentioning
confidence: 99%
“…[91][92][93][94] Cost-effectiveness, lower invasiveness and morbidity, and patient preferences (e.g., shorter treatment time) are additional factors that should be taken into consideration when making clinical decisions on the use of short dental implants. Clinical guidelines for case selection, treatment planning, surgical placement, prosthetic rehabilitation, risk assessment, and maintenance of short dental implants are essentially the same as those recommended for conventional implants, 95 with additional careful consideration of specific prosthetic aspects, such as crown-to-implant ratio and use of cantilever extensions, due to biomechanical concerns, particularly in sites with significant vertical bone atrophy and large interocclusal space. 96…”
Section: Short Implantsmentioning
confidence: 99%